Penumbra Aktie
WKN DE: A14Y65 / ISIN: US70975L1070
31.08.2021 22:05:00
|
Penumbra, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
ALAMEDA, Calif., Aug. 31, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021.
Event: Morgan Stanley 19th Annual Global Healthcare Conference
Date: Tuesday, September 14, 2021
Time: 11:00am EDT / 8:00am PDT
A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-morgan-stanley-19th-annual-global-healthcare-conference-301365519.html
SOURCE Penumbra, Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Penumbra Incmehr Nachrichten
22.04.25 |
Ausblick: Penumbra zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
08.04.25 |
Erste Schätzungen: Penumbra verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
17.02.25 |
Ausblick: Penumbra öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
03.02.25 |
Erste Schätzungen: Penumbra legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
29.10.24 |
Ausblick: Penumbra präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Penumbra Incmehr Analysen
Aktien in diesem Artikel
Penumbra Inc | 254,10 | 3,63% |
|